SCHEMBL6892982

SCHEMBL6892982

O=C(c1ccccc1)n1cnc(CCO)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.40
POLB P06746 1/20 0.37
CPB1 P15086 3/20 0.36
CPB2 Q96IY4 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
SLC6A7 Q99884 1/20 0.35
FDPS P14324 1/20 0.35
KMT2A Q03164 3/20 0.34
HPGD P15428 2/20 0.34
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
KCNH2 Q12809 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MGAM O43451 1/20 0.33
F2 P00734 1/20 0.33
AMY1A P0DUB6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15473181 0.83 BLM (0.41) NAMPTSLC6A7FDPSKMT2AHPGD
SCHEMBL15469274 0.79 GRN (0.41) NAMPTPOLBCPB1CPB2SMN1; SMN2
SCHEMBL9525142 0.73 MAPT (0.41) CYP2C19SLC6A7KMT2AHPGDGAA
SCHEMBL6172065 0.71 GPR119 (0.35) CPB1CPB2CYP2C19TDP1
SCHEMBL5242740 0.70 CPB2 (0.40) CPB1CPB2CYP2C19TDP1
SCHEMBL11148260 0.70 CPB2 (0.44) CPB1CPB2
SCHEMBL11270168 0.69 CPB2 (0.43) CPB1CPB2
SCHEMBL6896811 0.69 KDM5A (0.36) POLBCPB1CPB2SMN1; SMN2SLC6A7
SCHEMBL6896976 0.68 HPGDS (0.50) POLBCPB2CYP1A2CYP2C19TDP1
SCHEMBL1041048 0.67 SIRT2 (0.49) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0604409-B1 OLIGONUCLEOTIDE ANALOGS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION ISIS PHARMACEUTICALS INC (US) 2004-07-14 EP disclosed
EP-1418179-A2 Compositions and methods for detecting and modulating rna activity and gene expression ISIS PHARMACEUTICALS, INC. (US) 2004-05-12 EP disclosed
US-6262241-B1 ANTISENSE COMPOUNDS WHICH CLEAVE PHOSPHORODIESTER BONDS AND IMPROVE PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF OLIGONUCLEOTIDES, USEFUL IN DIAGNOSING DISEASES ISIS PHARMACEUTICALS, INC. 2001-07-17 US disclosed